EN DE
Watch Novotek AB for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Novotek AB (NTEK-B) fair value: what the stock is really worth

As of Oct 19, 2026: fair value (intrinsic value) of Novotek AB stock SEK 100, price SEK 70.30, upside +42.3%, quality 59 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Technology · SE · ISIN SE0000567752

NA Novotek AB logo Broad data Oct 2, 2026

Novotek AB

NTEK-B · ST

UndervaluedThe stock appears undervalued with acceptable quality.

The stock costs 30% less than our calculation considers fair.

Fair value kr 100.01 · Undervalued (+42.3%)
Healthy Growth (revenue 5y +9.5 %/yr in SEK)
Low debt
Generates free cash flow
2.6% dividend yield · Well covered
Ranks above peers (10/14)
Broad data
Quality 59/100
Thin margins · 7.2% net margin (TTM)
Moderate moat 52/100 · thin data

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 114.66 kr 33.16 Fair Value kr 100.01 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.

How to read this chart

60‑month range kr 33.16 – kr 114.66 · fair‑value band kr 69.16 – kr 131.28 · the kr 70.30 price screens below the kr 100.01 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.

Follow Novotek in your weekly email

Every Wednesday you see whether Novotek is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Novotek AB delivers solutions in the industrial IT and automation areas. The company designs, implements, evolves, and maintains its customers' systems for production management and control.

Show moreShow less

It serves the energy, food, pharmaceuticals, iron, steel, chemistry, petrochemicals, paper, pulp, manufacturing, and water and wastewater industries. The company is located in Sweden, Norway, Denmark, Finland, Benelux, the United Kingdom, Ireland, Switzerland, Austria, Germany, and France.

Novotek AB was incorporated in 1955 and is headquartered in Malmö, Sweden.

Stock analysis

Novotek AB (NTEK-B) currently trades at kr 70.30, while our model-based Fair Value estimate is kr 100.01, implying the stock looks roughly 29.7% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of kr 100.98 per share, and 17 of the 24 models we run sit above the kr 70.30 price.

Bear case: the Earnings-Based group reads lowest at kr 24.23, and 7 of the 24 models stay below the price. Data coverage for this calculation is high.

Scenario range: kr 69.16 (bear) to kr 131.28 (bull), the price of kr 70.30 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 59/100 (solid quality), in the Technology sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Novotek AB reported revenue of 503M SEK in FY2025 versus 391M SEK in FY2021, a compound +6.5%/yr. Reported net income was 39.1M SEK in FY2025, compounding −0.4%/yr from FY2021.

Key figures

Market cap 745M SEK (≈ $75.2M) Micro · P/E ratio 17.3 · P/S ratio 1.43 · EPS (TTM) kr 3.50 · Dividend yield 2.6% · Net margin 7.2% · Return on equity 17.5% · Return on assets (EBIT) 11.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 24% below its 52-week high and 39% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Technology peers we cover trades at 41% fair-value upside, at 42%, NTEK-B screens cheaper than that median.

Fair Value models

Bear kr 69.16 Fair Value kr 100.01 Bull kr 131.28
Price kr 70.30 · Upside +42.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (kr 1.36 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF kr 58.22 kr 76.57 kr 100.18 82
Growth DCF kr 58.65 kr 74.81 kr 94.44 80
Owner Earnings kr 63.51 kr 83.99 kr 110.35 78
All 24 models by family
DCF Models
FCF DCF kr 58.22 kr 76.57 kr 100.18 82
Owner Earnings kr 63.51 kr 83.99 kr 110.35 78
5Y Revenue Exit kr 60.88 kr 87.51 kr 120.92 73
5Y EBITDA Exit kr 87.18 kr 135.78 kr 191.75 75
5Y P/E Exit kr 78.18 kr 119.26 kr 161.58 71
10Y Revenue Exit kr 57.93 kr 80.24 kr 109.07 67
10Y EBITDA Exit kr 74.33 kr 110.30 kr 157.19 68
10Y P/E Exit kr 69.16 kr 100.01 kr 136.69 64
Earnings-Based
Graham-Dodd kr 29.22 kr 83.10 kr 109.48 65
Lynch FV kr 16.96 kr 24.23 kr 31.50 61
PEG = 1.0 kr 16.96 kr 24.23 kr 31.50 57
EPV kr 51.32 kr 56.50 kr 60.80 74
Multiples
P/E Multiple kr 90.23 kr 120.31 kr 150.38 63
P/S Multiple kr 54.78 kr 73.04 kr 91.30 58
P/B Multiple kr 24.38 kr 32.51 kr 40.63 55
EV/EBIT kr 117.73 kr 152.74 kr 187.75 66
EV/EBITDA kr 120.28 kr 156.14 kr 192.00 67
EV/Revenue kr 65.79 kr 88.55 kr 111.31 54
Asset-Based
NCAV (Graham) kr 0.8600 kr 1.31 kr 1.63 55
Growth DCF
Growth DCF kr 58.65 kr 74.81 kr 94.44 80
Rev-Margin DCF kr 60.88 kr 87.79 kr 118.01 73
Economic Profit
Residual Income kr 24.81 kr 30.62 kr 42.06 76
ROIC Compounder kr 52.96 kr 60.27 kr 67.59 72
Growth Earnings
Growth-Adj P/E kr 70.69 kr 100.98 kr 131.28 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 59/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 48
How much profit the company makes from its sales and capital
Quality Growth 23
Are margins and returns getting better?
Cashflow 56
Do the profits arrive as real cash?
Financial strength 79
Debt, balance sheet and risk of trouble
Investment 65
Does it invest with discipline instead of growing at any price?
Low Volatility 72
How calm the share price moves, does not count
Momentum 45
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 33
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 85/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+2.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.5%
Start year 2020 (pandemic). Over 10 years: +8.7% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+9.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+6.6%
Dividend (yield on the price)2.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.6.6% vs 10.3%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.12% → 11%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+7.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Sweden: IMF forecast 2.0% a year to 2030, 2.9% from 2016 to 2025) that is about +5.6% a year for the price.

Watch NTEK-B, get fair value alerts →

Compare Novotek AB with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Information Technology Services · 463 stocks

Beats the industry median on 10/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 59 · Above median
Fair Value upside +42.3% · Above median
Profitability
Return on equity (12 months) 17.5% · Top 25%
Return on assets 6.4% · Above median
Net margin (12 months) 7.2% · Above median
Operating margin (12 months) 7.9% · Above median
Growth and dividend
Revenue growth (quarter YoY) 12.1% · Above median
Dividend yield (12 months) 2.6% · Above median
Balance sheet
Debt / equity 0.01× · Below median

Valuation Multiplesvs Information Technology Services median · lower = cheaper

P/E (12 months) 17.3× · Cheaper than median
P/B 3.25× · Pricier than median
P/S (12 months) 1.43× · Pricier than median
Price / free cash flow 17.7× · Pricier than median
EV/EBITDA 11.0× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)90 · sector 43
FUTURE (revenue growth)61 · sector 29
PAST (return on equity)70 · sector 36
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)51 · sector 40

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Information Technology Services stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Technology stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Novotek AB Fair Value". https://www.fairvalue-calculator.com/stock/NTEK-B

Frequently asked questions

Is Novotek AB (NTEK-B) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of kr 100.01 versus a price of kr 70.30, about +42% upside (undervalued).
What is the fair value of NTEK-B?
Our model-based fair value for Novotek AB is kr 100.01 (as of Oct 2, 2026), built from audited fundamentals. The current price: kr 70.30.
What is the quality score of NTEK-B?
Novotek AB has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Novotek AB (NTEK-B)?
Our model-based price target is the fair value of kr 100.01 (as of Oct 2, 2026) from 24 valuation models. Cautious scenario kr 69.16, optimistic scenario kr 131.28. It is a calculation from audited fundamentals, not an analyst target.
What is the Novotek AB stock forecast for 2026?
Our models put fair value at kr 100.01, about +42% upside versus a price of kr 70.30 (undervalued). Cautious scenario kr 69.16, optimistic scenario kr 131.28. The calculation is refreshed regularly with new filings.
What is the revenue of Novotek AB (NTEK-B)?
Novotek AB reported trailing-twelve-month revenue of about 520M SEK (latest available figure, as of Oct 2, 2026).
Does Novotek AB pay a dividend?
Novotek AB currently shows a dividend yield of 2.56% relative to its recent price (as of Oct 2, 2026).
What growth is priced into Novotek AB (NTEK-B)?
For today's price to be fair in a discounted-cash-flow model, Novotek AB would have to grow free cash flow by +7.7 % per year for five years (discount rate 11.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.5 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of NTEK-B use?
Our models discount Novotek AB at 11.2 %: a base by market capitalisation (micro), damped by beta 0.58, country premium for Sweden. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Novotek AB that is +7.7 % per year a year over ten years, using the same discount rate (11.2 %) and the same formula as our fair value.
How much growth has Novotek AB (NTEK-B) delivered so far?
Over the past 5 years revenue at Novotek AB grew +9.5 % a year. The price currently implies +7.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Novotek AB (NTEK-B) growing?
The median revenue growth in the sector is +10.7 % a year. That is the yardstick for the growth priced into Novotek AB (+7.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Novotek AB (NTEK-B)?
The free-cash-flow yield on the price is 5.64 %: that much free cash flow Novotek AB produces per unit of market value. When it exceeds the discount rate of our models (11.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Novotek AB (NTEK-B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Novotek AB it is kr 100.01 per share (as of Oct 2, 2026), against a price of kr 70.30. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Novotek AB stock overvalued or undervalued in 2026?
As of Oct 2, 2026, NTEK-B trades below its calculated fair value: price kr 70.30, fair value kr 100.01, a gap of about +42% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NTEK-B?
No. The price is what the market pays today (kr 70.30); the fair value is what the company's own numbers justify (kr 100.01). For Novotek AB the two are kr 29.71 per share apart. That gap is exactly why we show both numbers side by side.
How much is Novotek AB worth?
The market values Novotek AB at about 745M SEK (market capitalisation, as of Oct 2, 2026). Per share that is kr 70.30; our models calculate a fair value of kr 100.01 per share.
What do the bullish and bearish scenarios say about NTEK-B?
Our models span a range for Novotek AB: cautious scenario kr 69.16, base kr 100.01, optimistic kr 131.28 per share (as of Oct 2, 2026, price kr 70.30). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of NTEK-B?
Novotek AB trades at a price-to-earnings ratio of 17.3 (as of Oct 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 100.01 is built from several models across several years. Other multiples: P/B 3.3, P/S 1.4, EV/EBITDA 11.0.
How solid is the balance sheet of Novotek AB (NTEK-B)?
Balance-sheet figures for Novotek AB (as of Oct 2, 2026): return on equity 17.5%, debt of 0.01 per unit of equity. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is NTEK-B from its 52-week high?
Novotek AB trades at kr 70.30, about 24% below its 52-week high of kr 92.31 and 39% above the low of kr 50.50 (as of Oct 19, 2026). Distance from the high says nothing about value: that is what the fair value of kr 100.01 is for.
Which stocks are comparable to Novotek AB?
From the same area (Technology) we also value International Business Machines Corporation, Accenture plc, Tata Consultancy Services Limited, Infosys Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Novotek AB stock attractive at the current price?
The data as of Oct 2, 2026: price kr 70.30, calculated fair value kr 100.01 (+42%), Quality Score 59/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NTEK-B calculated?
We run Novotek AB through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 100.01, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.9 % above its aggregate fair value. Novotek AB currently trades 30 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Novotek AB (NTEK-B)?
The closing price on Oct 19, 2026 was kr 70.30. Our model-based fair value is kr 100.01, about +42% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Novotek AB right now?
Solid quality (59/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (kr 69.16 to kr 131.28) leaves room in how you read the outcome.
Where does the earnings growth of Novotek AB (NTEK-B) come from?
Earnings per share at Novotek AB grew +14.0 % a year from 2014 to 2025. Broken into its drivers: revenue per share +9.7 %, EBIT margin +4.3 %, tax rate +0.7 %, residual (interest, one-offs) −1.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Novotek AB

How large is the market capitalisation of Novotek AB (NTEK-B)?
The market capitalisation of Novotek AB is 745M SEK (≈ $75.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Novotek AB (NTEK-B)?
The price-to-sales ratio of Novotek AB is 1.43 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Novotek AB (NTEK-B)?
Earnings per share at Novotek AB are kr 3.50 (price ÷ EPS = P/E 17.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Novotek AB (NTEK-B)?
The dividend yield of Novotek AB is 2.6% (payout 51.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Novotek AB (NTEK-B)?
The net margin of Novotek AB is 7.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Novotek AB (NTEK-B)?
The return on equity (ROE) of Novotek AB is 17.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Novotek AB (NTEK-B)?
On an EBIT basis the return on assets of Novotek AB is 11.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Novotek AB (NTEK-B)?
The operating margin of Novotek AB is 7.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Novotek AB (NTEK-B)?
Revenue at Novotek AB is growing +12.1% versus a year earlier (3y avg +5.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Novotek AB (NTEK-B)?
Earnings per share at Novotek AB are growing +74.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Novotek AB (NTEK-B) hold?
Novotek AB holds more cash than debt, 116M SEK net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Novotek AB in the live analysis

One click puts Novotek AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.